Patient engagement platform Luma Health has raised a bumper Series C round of funding.
The company offers software for automating patient healthcare journeys, integrating with electronic health records and healthcare IT vendors for functions such as scheduling and patient communication. Its customers include over 550, health systems, hospitals, health centres and clinics in the United States.
The company’s latest $130mn Series C round was led by FTV Capital, alongside existing investors, and brings total funds raised to over $160mn.
“In the tight-knit community of enterprise healthcare, word of Luma Health has gotten out,” said Adnan Iqbal, Luma Health’s co-founder and CEO. “With this investment, we will continue to meet the demands of leading healthcare delivery systems nationwide and deliver on our promise to our customers: helping transform the complexities of healthcare into convenient, seamless experiences for their patients.”
Luma Health said it would use the funds to attempt to reach a quarter of all Americans by 2022, as well as scale internationally and develop its platform.
“A partnership with Luma Health was the only choice for FTV,” said Alex Mason, partner at FTV Capital. “As deeply sector-focused investors with a rich history in healthcare technology, we’ve spent significant effort evaluating the entire patient engagement landscape in search of a solution that can truly transform the patient journey from one that’s fragmented and disconnected to one that’s unified and seamless.”
The pandemic has proved to be a sea change in the patient experience, with telehealth opportunities blooming. Challenges remain, however. Research from CRM and process automation company Pegasystems issued last month looked into healthcare consumers’ experiences during the pandemic, and found that 55% of consumers thought that navigating the healthcare system remains difficult.
“While the healthcare industry made strides to deliver connected, simplified experiences during a tumultuous year, the reality is that consumers still bear the brunt of navigating a very complex ecosystem,” said Kelli Bravo, vice president and global industry market lead, healthcare and life sciences, Pegasystems, at the time.